Are 90% success rate claims a red flag?

Yes, when stated without context. The clinical literature does show meaningful response rates for ketamine in treatment-resistant depression, PTSD, and certain chronic pain conditions, but those rates are condition-specific, study-specific, and protocol-specific. A clinic that quotes a single global success number across every diagnosis is overselling the evidence. Ask which study, which condition, which dose, and which response criteria the number is based on.

Is a package deal always a red flag?

No. Bundling the standard induction series can be reasonable because the evidence base for ketamine is built on multi-session protocols, and a package can make the math clearer. The red flag is when the pricing structure pressures you to commit before any medical or psychiatric screening, or when the package hides what is and is not included. Ask for a written breakdown before you sign anything.

What if the clinic is run by an RN with an off-site MD medical director?

That is not automatically disqualifying, but you should ask who is physically present during your infusion and what training they have in airway management, advanced cardiac life support, and managing dissociation. Ask whether a CRNA, anesthesiologist, or physician is in the room. The answer matters because ketamine is an anesthetic and rare adverse events are airway and cardiovascular events.

Is at-home ketamine telehealth automatically a red flag?

It is a different model with different risks rather than a blanket warning sign. The FDA issued a drug safety communication in October 2023 about compounded oral ketamine specifically, citing risks of sedation, dissociation, respiratory depression, and abuse outside a monitored setting. Some at-home programs are thoughtful, some are not. Read our comparison of at-home and in-clinic care before making a decision.

How can I check whether a ketamine clinic is legitimate?

Use a short checklist. Look up the medical license of the prescribing clinician and the CRNA or anesthesia provider on your state board website. Check whether the clinic is listed in the ASKP3 pledge directory. Search the Better Business Bureau for complaints and the state attorney general for consumer alerts. Then call and ask three questions: who is in the room during the infusion, what your medical screening will include, and how integration or follow-up works.

Red Flags in Ketamine Clinic Marketing: What to Walk Away From

Why the ketamine market attracts marketing problems

Ketamine works through the glutamate system, blocking NMDA receptors and triggering changes in synaptic signaling that can lift depression, dampen pain, and soften the trauma response. That mechanism is real, and the clinical evidence behind it is genuinely encouraging for several conditions. Ketamine is FDA-approved as an anesthetic; its use for depression, anxiety, PTSD, OCD, and chronic pain is off-label. The only psychiatric ketamine product the FDA has approved is intranasal esketamine (Spravato) for treatment-resistant depression and major depressive disorder with acute suicidal ideation.

That gap between strong patient demand and a narrow approved indication is where bad marketing thrives. Ketamine clinics are largely cash-pay, lightly regulated at the state level, and competing for a desperate audience. Some operators respond with careful, conservative practice. Others reach for the language of certainty, because certainty sells. Knowing the difference is your protection.

What follows are the specific patterns the FDA, the AANA, ASKP3, and consumer-protection bodies like the Better Business Bureau have flagged in the ketamine space, plus the questions to ask in their place. The goal is not to scare you away from a treatment that helps real people. It is to help you choose a clinic that will treat you like a patient rather than a transaction.

Red flag 1: outcome promises and one-shot-fix language

Truth-in-advertising standards are not a guess. The Better Business Bureau’s Code of Advertising and the FTC’s general endorsement and substantiation rules require that health claims be supported by competent and reliable scientific evidence and presented in context. A clinic that promises you will get better, that calls ketamine a one-shot answer for depression or trauma, or that quotes a single across-the-board response rate is not following those standards.

The honest version sounds different. The research base shows meaningful response rates — often in the 50% to 70% range for treatment-resistant depression in well-designed trials — but those rates are condition-specific, dose-specific, and depend on follow-up care. Studies indicate ketamine helps a substantial minority to majority of patients with specific conditions; it does not work for everyone, and reputable clinicians say so out loud.

Red flag 2: no medical or psychiatric screening before booking

If a clinic will put you on the schedule before reviewing your medical history, your psychiatric history, your current medications, and your cardiovascular status, that is a problem. The 2024 ASKP3 Standards of Care for Ketamine Therapy require documented patient screening, informed consent that discloses the off-label nature of the treatment, vital-sign monitoring during administration, and a clinician trained in ACLS and airway management on site. Skipping the front end of that workflow is not a minor shortcut.

Screening matters because ketamine has real contraindications and precautions: uncontrolled hypertension, certain cardiac conditions, active psychosis, active substance use disorder of specific patterns, pregnancy, and several medication combinations all change the risk picture. We have written about who we decline and why. A clinic that never declines anyone is a clinic that is not screening.

Red flag 3: vagueness about who is in the room during the infusion

Ask directly: who is physically present during my infusion, what is their training, and what monitoring equipment is in use? The answer should be specific. The American Association of Nurse Anesthesiology’s 2020 Standards for Office-Based Anesthesia Practice require a qualified anesthesia provider in continuous attendance, with continuous monitoring of oxygenation, ventilation, circulation, and level of consciousness. That is the floor, not the ceiling.

If the answer is “a medical assistant will check on you” or “the doctor is in the building somewhere,” that is below the standard ASKP3 and AANA describe. A CRNA-led model puts an anesthesia-trained clinician on site for every infusion, which is the model we use; a CRNA is specifically trained in airway management and the kinds of cardiovascular and dissociative responses that ketamine can produce. Safety in ketamine therapy is mostly about preventing rare events from becoming serious ones, which requires the right person watching at the right moment.

Red flag 4: no integration partner and no follow-up plan

Ketamine opens what researchers describe as a window of heightened neuroplasticity in the days after a session. What patients do with that window matters. A clinic that hands you a series of infusions with no conversation about therapy, no referral pathway, and no follow-up structure is leaving the most important part of the work on the floor.

Reputable programs have a plan. That can mean an in-house psychotherapist, a working list of integration therapists in your area, scheduled check-in calls, validated outcome measures repeated over time, or all of the above. If you ask “what does follow-up look like?” and the answer is a price for the next infusion, that is a sales-driven model rather than a clinical one.

Red flag 5: pricing that hides what is actually included

Cost transparency is a fairness issue and a consumer-protection issue. The Better Business Bureau’s advertising standards, and the broader FTC framework on deceptive pricing, expect that material conditions of a price are disclosed. That includes what is bundled, what is extra, what happens if you cancel, and what the consultation actually costs.

Bundled induction packages can be reasonable because the evidence is built on multi-session protocols. The red flag is when pricing is used to lock you in before screening, or when add-ons appear after you have already started. We publish our ketamine therapy cost openly: $475 per session, with no surprise add-ons, and consultation pricing disclosed up front. You should expect that level of clarity from anyone you consider.

Red flag 6: pushing compounded oral or at-home ketamine as equivalent to IV

This is the one the FDA has spoken about most directly. In October 2023, the U.S. Food and Drug Administration issued a Drug Safety Communication titled Compounded Ketamine Products, Including Oral Formulations: FDA Alerts Patients and Health Care Professionals of Potential Risks. The agency warned that ketamine is not FDA-approved for any psychiatric disorder, that compounded oral ketamine has been associated with sedation, dissociation, respiratory depression, and abuse risks, and that the FDA is not aware of evidence that compounded oral ketamine is safer or more effective than FDA-approved psychiatric medications.

That does not mean every telehealth program is a red flag. It means a clinic that markets compounded oral or at-home ketamine as functionally equivalent to a monitored IV infusion is glossing over a real safety distinction the FDA has formally flagged. Our take on the trade-offs lives in at-home ketamine vs clinic. The right answer depends on the patient and the protocol; the wrong answer is a marketing one-liner that erases the difference.

Red flag 7: no clear answer on adverse-event handling

Ask: what happens if my blood pressure spikes? What happens if I have a panic response or severe dissociation? What happens if I have a cardiac event? A clinic that meets ASKP3 and AANA standards has a documented answer: continuous monitoring, on-site ACLS-trained personnel, an emergency action plan, and a pathway to higher levels of care. Vagueness here is not modesty. It is a signal.

Questions to ask before you book anywhere

Before you commit, ask any clinic the same short list:

Who is physically in the room during my infusion, and what is their training?
What does my medical and psychiatric screening include, and can I see the consent form before I pay?
How do you handle integration and follow-up, and do you have therapists you refer to?
What is the total cost, what is included, and what is your cancellation and refund policy?
How do you handle adverse events, and what is your emergency action plan?
Do you follow ASKP3 standards of care, and are you listed in their pledge directory?

You can also verify the clinic operationally: state medical board license lookup for the prescriber and CRNA, ASKP3 directory, Better Business Bureau profile, and any state attorney general consumer alerts. Tennessee patients can read our overview of state ketamine clinic regulations for the local context. None of this is paranoid. It is the same homework you would do before any cash-pay medical procedure.

If a consult feels rushed, evasive, or pre-sold, trust that. Walk away. There are clinics that will treat you like a patient, and the difference is usually visible inside the first phone call.